Lotte Group Chairman Shin Dong-bin (left) visits Lotte Biologics' newly completed Plant 1 in Songdo, Incheon, on Friday. During the visit, Shin reaffirmed the CDMO unit's role as a key future growth engine for the conglomerate and called for swift progress on pilot operations and validation work in the second half of the year. The facility houses eight 15,000-liter bioreactors with a total production capacity of 120,000 liters. (Lotte Group)